Discontinued — last reported Q4 '25
Eli Lilly Pre-Tax Income increased by 14.3% to $8.27B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 64.1%, from $5.04B to $8.27B. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income shows an upward trend with a 43.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
This represents the total pool of earnings available to be split between the government and shareholders.
A company's total earnings including both operating and non-operating items, before the provision for income taxes is ap...
Used to calculate the effective tax rate when compared to the final tax expense.
is_income_before_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.59B | $1.25B | $1.84B | $2.05B | $1.09B | $1.57B | $2.10B | $1.53B | $2.09B | $427.20M | $2.51B | $2.54B | $3.52B | $1.59B | $5.04B | $3.46B | $6.78B | $7.23B | $8.27B |
| QoQ Change | — | -21.9% | +47.7% | +11.6% | -46.9% | +43.5% | +33.9% | -27.0% | +36.6% | -79.5% | +487.3% | +1.1% | +38.7% | -54.8% | +217.2% | -31.4% | +96.1% | +6.7% | +14.3% |
| YoY Change | — | — | — | — | -31.6% | +25.7% | +13.9% | -25.5% | +91.5% | -72.7% | +19.7% | +65.8% | +68.4% | +271.8% | +100.8% | +36.3% | +92.7% | +355.3% | +64.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.